𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Fluorescent investigations of binding of phenprocoumon to α1-acid glycoprotein

✍ Scribed by M. Otagiri; T. Maruyama; T. Imai; Y. Imamura


Publisher
John Wiley and Sons
Year
1987
Tongue
English
Weight
323 KB
Volume
76
Category
Article
ISSN
0022-3549

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Phenprocoumon Binding to Bovine and Huma
✍ Jason Lauritsen; Edward C. Shane 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 92 KB

The binding of the anticoagulant drug phenprocoumon to bovine and human a 1 -acid glycoprotein (AGP) was studied using a fluorescence titration technique. Phenprocoumon was found to have one moderate strength binding site on bovine AGP with n Å (0.78 { 0.04) and a Scatchard association constant, K Å

Enantioselective binding of propranolol,
✍ Kazuhiko Hanada; Toshikuni Ohta; Masahiko Hirai; Miki Arai; Hiroyasu Ogata 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 201 KB

We investigated the binding of propranolol (PL), disopyramide (DP), and verapamil (VP) enantiomers by human alpha(1)-acid glycoprotein (AGP; also called orosomucoid) and the relationships between the extent of drug binding and lipophilicity, desialylation, and genetic variants of AGP. Desialylation

Binding of several phenothiazine neurole
✍ Safaa El-Gamal; Uwe Wollert; Walter E. Müller 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 388 KB

The interaction of several phenothiazine neuroleptics with alpha 1-acid glycoprotein was investigated using circular dichroism and equilibrium dialysis techniques. For chlorpromazine only, one high-affinity binding site of the protein was found. The binding of the drug to this single site generated

Binding of disopyramide to α1-acid glyco
✍ R. L. G. Norris; P. J. Ravenscroft; J. T. Ahokas; M. Henry 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 379 KB

A modification of equilibrium dialysis in which a]-acid glycoprotein and plasma compete directly for disopyrarnide has been used in conjunction with binding curves to measure the extent of the al-acid glycoprotein-disopyramide interaction. At concentrations in the therapeutic range, 80-90% of disopy